Is Arvinas Inc (ARVN) a Bad Choice in Biotechnology Thursday?

Arvinas Inc (ARVN) is around the top of the Biotechnology industry according to InvestorsObserver. ARVN received an overall rating of 57, which means that it scores higher than 57 percent of all stocks. Arvinas Inc also achieved a score of 74 in the Biotechnology industry, putting it above 74 percent of Biotechnology stocks. Biotechnology is ranked 48 out of the 148 industries.

ARVN has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on ARVN!

See Full ARVN Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 57 means the stock is more attractive than 57 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Arvinas Inc Stock Today?

Arvinas Inc (ARVN) stock is lower by -9.82% while the S&P 500 has risen 0.13% as of 10:25 AM on Thursday, Nov 30. ARVN is lower by -$2.45 from the previous closing price of $24.99 on volume of 245,461 shares. Over the past year the S&P 500 is higher by 11.68% while ARVN is lower by -45.08%. ARVN lost -$5.52 per share the over the last 12 months. Click Here to get the full Stock Report for Arvinas Inc stock.